Edwards Lifesciences revives Fintiv challenge
Medtech company wins reversal of earlier ruling | Door opens to mount a challenge of controversial rule | USPTO director‘s updated guidelines influence court’s reasoning.
Don’t distort enablement law, Amgen tells SCOTUS
Sanofi and Regeneron accused of wanting to change patent system | The US Supreme Court will decide whether a controversial court decision should stand.
Gilead defeats immunity bid in hepatitis C patent case
The University of Minnesota had raised three key issues on appeal | Sovereign immunity was at the heart of the years-long dispute.
Genentech seeks ‘tens of millions in unpaid royalties’ in licence dispute
The Roche subsidiary says the licensee owes payments on “stockpile” of MS drug Tysabri.
WIPO: Pharma patents dwindle against record total growth
Health-related patents fell during 2022 against a backdrop of record global patents filed | Biotechnology was fastest growing field among Patent Cooperation Treaty applications | COVID-19 pandemic caused large falls in goods classes such as pharmaceuticals.
Jazz Pharma loses patent case over narcolepsy drug
Court finds no method-of-use in patent claims | Judgment is a win for rival firm Avadel.
Trial set for Gilead HIV antitrust claims case
Gilead, Johnson & Johnson and others will face trial in May | Class-action suit involves allegations of anticompetitive practices.
Sanofi backed by big pharma and more in SCOTUS clash
Case focuses on the enablement scope of patents | Amici curiae argue Amgen patents are too broad | Pfizer | Eli Lilly | AstraZeneca| Sanofi | Genentech | Bayer | Gilead Sciences| Johnson & Johnson.
US govt wades into Moderna COVID row
The pharma company is accused of using patented tech for a drug-delivery system without authorisation | Moderna sought to escape the suit by claiming that its contract with the US government conferred immunity.
Federal Circuit rejects Dartmouth College bid to overturn patent ruling
Dietary supplements containing a form of vitamin B3 found in cow’s milk are unpatentable | Judge cites Myriad noting that the “act of isolating the NR compared to how NR naturally exists in milk is not sufficient, on its own, to confer patent eligibility”.